RGS20

UniProt ID: O76081
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

RGS20 (Regulator of G-protein signaling 20, also known as RGSZ1 or Gz-GAP) is a member of the RZ subfamily of RGS proteins. It functions as a GTPase-activating protein (GAP) that accelerates the intrinsic GTPase activity of heterotrimeric G protein alpha subunits, thereby terminating GPCR signaling. RGS20 exhibits strong selectivity for Galpha-z and can also act on Galpha-i1/i3 subunits but not Galpha-i2 or Galpha-s. The protein is brain-enriched with high expression in the caudate nucleus and temporal lobe. It modulates mu-opioid receptor and melatonin MT1 receptor signaling. RGS20 contains a C-terminal RGS domain for GAP activity and an N-terminal cysteine-rich region for membrane association via palmitoylation. The protein shuttles between cytoplasm, membrane, and nucleus and shows stimulus-dependent relocalization to the Golgi complex.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005096 GTPase activator activity
IBA
GO_REF:0000033
ACCEPT
Summary: RGS20 is a well-characterized GTPase-activating protein (GAP) that accelerates GTP hydrolysis on heterotrimeric G protein alpha subunits. This is the core biochemical function of RGS proteins, supported by direct biochemical assays demonstrating GAP activity with marked preference for Galpha-z over other Gi family members [PMID:9748279].
Reason: This annotation represents the core molecular function of RGS20. The protein was originally identified and characterized as a Gz-selective GAP. IBA annotations based on phylogenetic inference are appropriate for conserved RGS domain function.
Supporting Evidence:
PMID:9748279
Biochemical characterization of recombinant RGSZ1 protein revealed that RGSZ1 was indeed a GAP and, most significantly, showed a marked preference for Gzalpha over other members of the Gialpha family.
GO:0009898 cytoplasmic side of plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: RGS20 is anchored to membranes through palmitoylation at its N-terminal cysteine-rich region, allowing it to localize to the cytoplasmic face of the plasma membrane where it can interact with activated G protein alpha subunits [PMID:10791963, leung2017theroleof].
Reason: This annotation correctly describes the membrane localization mode of RGS20, which is consistent with its function in regulating membrane-associated GPCR signaling.
Supporting Evidence:
PMID:10791963
RGSZ, which shares with RGS-GAIP a cysteine-rich string in its N-terminal region, localized to the Golgi complex in COS-7 cells.
GO:0045744 negative regulation of G protein-coupled receptor signaling pathway
IBA
GO_REF:0000033
ACCEPT
Summary: By accelerating GTP hydrolysis on Galpha subunits, RGS20 terminates GPCR signaling, acting as a negative regulator. Studies have shown it modulates mu-opioid receptor and melatonin MT1 receptor signaling [PMID:20859254, leung2017theroleof].
Reason: This represents a core biological function of RGS20. The negative regulatory role in GPCR signaling is the direct consequence of its GAP activity and is well supported by evidence from receptor-specific studies.
Supporting Evidence:
PMID:20859254
Here, we characterized the molecular complex of the melatonin MT₁ receptor, which directly and constitutively couples to G(i) proteins and the regulator of G-protein signalling (RGS) 20
GO:0003924 GTPase activity
IEA
GO_REF:0000117
REMOVE
Summary: This IEA annotation is technically incorrect for RGS20. RGS proteins do not possess intrinsic GTPase activity; rather, they act as GTPase-activating proteins (GAPs) that enhance the intrinsic GTPase activity of Galpha subunits. RGS20 stimulates hydrolysis of GTP bound to Galpha-z/i but does not hydrolyze GTP itself.
Reason: RGS20 does not have GTPase activity. It has GTPase activator activity (GAP activity), meaning it accelerates the GTPase activity of its substrates (Galpha-z, Galpha-i). This is a common over-annotation error where GAP function is confused with GTPase activity. The correct term is GO:0005096 (GTPase activator activity).
GO:0005634 nucleus
IEA
GO_REF:0000044
ACCEPT
Summary: RGS20 has been shown to localize to the nucleus in addition to cytoplasm and membrane compartments. The protein shuttles between cytoplasm/membrane and nucleus [PMID:10791963, UniProt O76081].
Reason: Nuclear localization of RGS20 is documented in the literature and UniProt. This IEA annotation is consistent with experimental observations showing RGS proteins can localize to the nucleus.
Supporting Evidence:
PMID:10791963
These results demonstrate that RGS proteins localize in the nucleus, the cytoplasm, or shuttle between the nucleus and cytoplasm as nucleo-cytoplasmic shuttle proteins.
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Cytoplasmic localization of RGS20 is well established and has been confirmed by experimental studies using confocal microscopy of GFP-tagged constructs [PMID:10791963].
Reason: This annotation is consistent with experimental evidence showing cytoplasmic pools of RGS20.
Supporting Evidence:
PMID:10791963
RGS proteins localize differentially within cells as a result of structural differences among these proteins that do not appear to be important determinants for their G protein-regulating activities
GO:0007186 G protein-coupled receptor signaling pathway
IEA
GO_REF:0000117
ACCEPT
Summary: RGS20 is directly involved in GPCR signaling by modulating the duration and intensity of signaling through its GAP activity on Galpha subunits.
Reason: This annotation is too general but not incorrect. RGS20 is a regulator of GPCR signaling pathways. The more specific term GO:0045744 (negative regulation of GPCR signaling) is already annotated and more informative.
GO:0009968 negative regulation of signal transduction
IEA
GO_REF:0000043
ACCEPT
Summary: This is a broad parent term that encompasses the more specific function of RGS20 in negatively regulating GPCR signaling.
Reason: While this annotation is correct, it is more general than the specific annotation for GPCR signaling pathway regulation. It is acceptable as a broader classification but the more specific term GO:0045744 is more informative.
GO:0016020 membrane
IEA
GO_REF:0000044
ACCEPT
Summary: RGS20 associates with membranes via its N-terminal cysteine-rich region through palmitoylation. This is documented in UniProt and supported by experimental evidence.
Reason: Membrane association of RGS20 is well-documented. While the more specific term GO:0009898 (cytoplasmic side of plasma membrane) is also annotated, this broader term is acceptable.
GO:0005515 protein binding
IPI
PMID:17353931
Large-scale mapping of human protein-protein interactions by...
MARK AS OVER ANNOTATED
Summary: This annotation derives from a large-scale IP-MS study of protein-protein interactions. RGS20 was identified in interaction screens, but this generic term does not provide functional insight. RGS20 binds specifically to Galpha-z/i subunits and GPCRs like the MT1 melatonin receptor [PMID:20859254].
Reason: 'Protein binding' is uninformative and should be replaced with more specific molecular function terms. RGS20's functional interactions are better captured by terms like 'G-protein alpha-subunit binding' or 'GTPase activator activity'.
Supporting Evidence:
PMID:17353931
We report the first large-scale study of protein-protein interactions in human cells using a mass spectrometry-based approach.
GO:0005515 protein binding
IPI
PMID:20859254
Molecular organization and dynamics of the melatonin MT₁ rec...
MODIFY
Summary: This study characterized the MT1 receptor/RGS20/Gi protein complex, demonstrating direct physical interaction between RGS20 and the melatonin MT1 receptor. A more specific term would be appropriate.
Reason: The study demonstrates specific receptor binding. A more appropriate annotation would be a term describing interaction with GPCRs or melatonin receptors. However, since specific GO terms for 'melatonin receptor binding' may not exist, this could be replaced with 'signaling receptor binding' (GO:0005102) or kept with annotation indicating the specific binding partner.
Proposed replacements: signaling receptor binding
Supporting Evidence:
PMID:20859254
Here, we characterized the molecular complex of the melatonin MT₁ receptor, which directly and constitutively couples to G(i) proteins and the regulator of G-protein signalling (RGS) 20
GO:0005515 protein binding
IPI
PMID:21516116
Next-generation sequencing to generate interactome datasets.
MARK AS OVER ANNOTATED
Summary: This study describes a high-throughput method (Stitch-seq) for generating interactome datasets using next-generation sequencing. RGS20 was identified in interactions but generic protein binding is uninformative.
Reason: High-throughput interactome studies provide evidence for interactions but the generic 'protein binding' term does not add functional information beyond what is captured by more specific terms.
Supporting Evidence:
PMID:21516116
We describe a massively parallel interactome-mapping pipeline, Stitch-seq, that combines PCR stitching with next-generation sequencing and used it to generate a new human interactome dataset
GO:0005515 protein binding
IPI
PMID:23088713
Protein interactions of the transcription factor Hoxa1.
KEEP AS NON CORE
Summary: This study characterized the interactome of the transcription factor HOXA1 and identified RGS20 as an interactor. The interaction with HOXA1 may be biologically relevant given HOXA1's role in development.
Reason: The HOXA1 interaction is documented in UniProt and may represent a real biological function, but 'protein binding' is uninformative. This interaction may not represent core RGS20 function as a GAP for G proteins.
Supporting Evidence:
PMID:23088713
RESULTS: To investigate the mode of action of mammalian Hoxa1, we characterized its interactome by a systematic yeast two-hybrid screening against ~12,200 ORF-derived polypeptides
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
MARK AS OVER ANNOTATED
Summary: This Cell paper describes a proteome-scale map of the human interactome network with approximately 14,000 high-quality binary protein-protein interactions. RGS20 interactions were identified as part of this systematic screen.
Reason: While the interactions are valuable for understanding the RGS20 network, the generic 'protein binding' annotation provides no functional insight.
Supporting Evidence:
PMID:25416956
Here, we describe a systematic map of ?14,000 high-quality human binary protein-protein interactions
GO:0005515 protein binding
IPI
PMID:29892012
An interactome perturbation framework prioritizes damaging m...
MARK AS OVER ANNOTATED
Summary: This study developed an interactome perturbation framework to prioritize damaging missense mutations in developmental disorders. RGS20 was included in the interactome analysis.
Reason: The study provides valuable network-level information but 'protein binding' annotation is too general to be informative about RGS20 function.
Supporting Evidence:
PMID:29892012
Here we establish an experimentally and computationally integrated approach to investigate the functional impact of missense mutations in the context of the human interactome network and test our approach by analyzing ~2,000 de novo missense mutations found in autism subjects and their unaffected siblings
GO:0005515 protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
MARK AS OVER ANNOTATED
Summary: This study examined disruption of protein interactions by genetic variants across the allele frequency spectrum. RGS20 was included in the systematic evaluation of protein-protein interactions.
Reason: Generic protein binding annotation from high-throughput studies does not add functional insight.
Supporting Evidence:
PMID:31515488
To address this gap, we leverage the ExAC database of 60,706 human exomes to investigate experimentally the impact of 2009 missense single nucleotide variants (SNVs) across 2185 protein-protein interactions, generating interaction profiles for 4797 SNV-interaction pairs, of which 421 SNVs segregate at > 1% allele frequency in human populations
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: This study (BioPlex 3.0) created proteome-scale, cell-line-specific interaction networks through affinity-purification mass spectrometry, identifying 118,162 interactions in 293T cells.
Reason: While the BioPlex network is a valuable resource, 'protein binding' is too generic to be informative about specific RGS20 function.
Supporting Evidence:
PMID:33961781
The first, BioPlex 3.0, results from affinity purification of 10,128 human proteins-half the proteome-in 293T cells and includes 118,162 interactions among 14,586 proteins
GO:0007186 G protein-coupled receptor signaling pathway
TAS
Reactome:R-HSA-388396
ACCEPT
Summary: Reactome pathway annotation for GPCR downstream signaling. RGS20 participates in this pathway by regulating G protein activity.
Reason: This Reactome-based annotation correctly places RGS20 in GPCR signaling pathways where it functions as a regulator of Galpha-z and Galpha-i signaling.
GO:0003924 GTPase activity
TAS
Reactome:R-HSA-8982020
REMOVE
Summary: This Reactome annotation incorrectly assigns GTPase activity to RGS20. RGS20 does not hydrolyze GTP itself; it accelerates GTP hydrolysis by Galpha subunits.
Reason: This is an incorrect annotation. RGS20 has GTPase activator (GAP) activity, not GTPase activity. The Galpha subunits (Galpha-z, Galpha-i) are the GTPases; RGS20 activates their intrinsic GTPase activity. This appears to be a Reactome curation error conflating the GAP with its substrate.
GO:0003924 GTPase activity
TAS
Reactome:R-HSA-8982021
REMOVE
Summary: Same issue as above - incorrect assignment of GTPase activity to RGS20.
Reason: RGS20 is a GTPase activator (GAP), not a GTPase. This annotation incorrectly attributes GTPase enzymatic activity to RGS20 rather than the Galpha subunits whose GTPase activity it enhances.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8981892
ACCEPT
Summary: Reactome annotation indicating plasma membrane localization, consistent with RGS20's role in modulating membrane-associated GPCR signaling.
Reason: Plasma membrane localization is consistent with RGS20's function in regulating G protein signaling at the membrane and its palmitoylation-dependent membrane association.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8982012
ACCEPT
Summary: Duplicate plasma membrane annotation from Reactome pathway.
Reason: This is a duplicate annotation with the same term but different Reactome reference. Both are acceptable as they correctly indicate plasma membrane localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8982018
ACCEPT
Summary: Duplicate plasma membrane annotation from Reactome pathway.
Reason: Acceptable duplicate - correctly indicates plasma membrane localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8982019
ACCEPT
Summary: Duplicate plasma membrane annotation from Reactome pathway.
Reason: Acceptable duplicate - correctly indicates plasma membrane localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8982020
ACCEPT
Summary: Duplicate plasma membrane annotation from Reactome pathway.
Reason: Acceptable duplicate - correctly indicates plasma membrane localization.
GO:0005886 plasma membrane
TAS
Reactome:R-HSA-8982021
ACCEPT
Summary: Duplicate plasma membrane annotation from Reactome pathway.
Reason: Acceptable duplicate - correctly indicates plasma membrane localization.
GO:0005802 trans-Golgi network
IMP
PMID:10791963
Cytoplasmic, nuclear, and golgi localization of RGS proteins...
ACCEPT
Summary: The study by Chatterjee and Fisher (2000) showed that RGSZ (RGS20) localized to the Golgi complex in COS-7 cells. This localization is dependent on the N-terminal cysteine-rich region shared with RGS-GAIP.
Reason: This is a well-documented experimental finding. The study specifically examined RGS protein localization using confocal microscopy of GFP fusion proteins and showed that RGSZ localized to the Golgi complex, distinct from other RGS proteins which showed cytoplasmic or nuclear localization.
Supporting Evidence:
PMID:10791963
RGSZ, which shares with RGS-GAIP a cysteine-rich string in its N-terminal region, localized to the Golgi complex in COS-7 cells.
GO:0005737 cytoplasm
IMP
PMID:10791963
Cytoplasmic, nuclear, and golgi localization of RGS proteins...
ACCEPT
Summary: The same study demonstrated cytoplasmic localization of RGS proteins and showed that deletion of the N-terminal domain including the cysteine motif from RGSZ promoted nuclear localization, indicating the wild-type protein has cytoplasmic pools.
Reason: Experimental evidence from confocal microscopy studies supports cytoplasmic localization of RGS20.
Supporting Evidence:
PMID:10791963
Deletion of the N-terminal domain of RGSZ that includes the cysteine motif promoted nuclear localization of RGSZ.
GO:0005096 GTPase activator activity
TAS
PMID:9748279
RGSZ1, a Gz-selective regulator of G protein signaling whose...
ACCEPT
Summary: The original characterization of RGSZ1 (RGS20) by Glick et al. (1998) demonstrated that it acts as a GAP with marked preference for Galpha-z over other Galpha-i family members. This is the foundational paper establishing RGS20's biochemical function.
Reason: This is the primary experimental evidence establishing RGS20 as a GTPase-activating protein. The biochemical characterization showed clear GAP activity toward Galpha-z with selectivity over other Gi family members.
Supporting Evidence:
PMID:9748279
Biochemical characterization of recombinant RGSZ1 protein revealed that RGSZ1 was indeed a GAP and, most significantly, showed a marked preference for Gzalpha over other members of the Gialpha family.
GO:0008277 regulation of G protein-coupled receptor signaling pathway
TAS
PMID:9748279
RGSZ1, a Gz-selective regulator of G protein signaling whose...
ACCEPT
Summary: The study demonstrated that RGS20 regulates G protein signaling, consistent with its GAP activity toward Galpha-z. The phosphorylation state of Galpha-z affects susceptibility to RGS20 action.
Reason: This annotation correctly describes RGS20's role as a regulator of GPCR signaling. While the more specific term GO:0045744 (negative regulation) may be more precise, this term is also appropriate and supported by the cited reference.
Supporting Evidence:
PMID:9748279
Phosphorylation of Gzalpha by protein kinase C, an event known to occur in cells and that was previously shown to influence alpha-betagamma interactions of Gz, rendered the G protein much less susceptible to RGSZ1 action.

Core Functions

RGS20 functions as a GTPase-activating protein (GAP) that accelerates the intrinsic GTPase activity of heterotrimeric G protein alpha subunits, particularly Galpha-z and Galpha-i1/i3. This is the core biochemical function of RGS20.

References

Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Electronic Gene Ontology annotations created by ARBA machine learning models
Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs.
  • RGSZ localizes to the Golgi complex in COS-7 cells due to its N-terminal cysteine-rich region
  • Deletion of N-terminal domain promotes nuclear localization
  • RGS proteins localize in nucleus, cytoplasm, or shuttle between compartments
Large-scale mapping of human protein-protein interactions by mass spectrometry.
  • High-throughput IP-MS study identifying protein interactions
  • RGS20 identified in interactome screens
Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling.
  • RGS20 directly and constitutively couples to MT1 melatonin receptor
  • Forms ternary complex with MT1 receptor and Gi proteins
  • Demonstrates receptor specificity for RGS proteins
Next-generation sequencing to generate interactome datasets.
  • Describes Stitch-seq methodology for interactome mapping
Protein interactions of the transcription factor Hoxa1.
  • RGS20 identified as HOXA1 interactor
  • Suggests potential roles in cell signaling beyond core GAP function
A proteome-scale map of the human interactome network.
  • Proteome-scale binary protein-protein interaction map
  • Approximately 14,000 high-quality human PPIs identified
An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders.
  • Framework for analyzing missense mutation impact on interactome
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
  • Systematic evaluation of SNV impact on protein-protein interactions
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  • BioPlex 3.0 proteome-scale interaction network
  • Cell-line-specific interaction profiling
RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gzalpha.
  • RGSZ1 (RGS20) is a GAP with marked preference for Galpha-z
  • Expression limited to brain, particularly high in caudate nucleus
  • PKC phosphorylation of Galpha-z reduces susceptibility to RGSZ1 action
Reactome:R-HSA-388396
GPCR downstream signalling
Reactome:R-HSA-8981892
Active G alpha (z) binds RGS proteins
Reactome:R-HSA-8982012
G alpha (i):RGS dissociates to inactive G alpha (i)-i1/i2/i3
Reactome:R-HSA-8982018
G alpha (z):RGS complex dissociates to give inactive G alpha (z)
Reactome:R-HSA-8982019
Active G alpha (i)-i1/i2/i3 binds RGS proteins
Reactome:R-HSA-8982020
G alpha (i)-i1/i2/i3 in G (i):RGS complex is inactivated
Reactome:R-HSA-8982021
G alpha (z) in G alpha (z):RGS complex is inactivated

Suggested Questions for Experts

Q: What is the physiological significance of RGS20's stimulus-dependent relocalization to the Golgi?

Q: How does the interaction between RGS20 and transcription factors like HOXA1 relate to its core GAP function?

Q: What is the functional significance of the multiple RGS20 splice isoforms?

Suggested Experiments

Experiment: Characterize the substrate specificity of RGS20 isoforms for different Galpha subunits

Hypothesis: Different RGS20 isoforms may have distinct preferences for Galpha-z vs Galpha-i substrates

Experiment: Investigate the role of RGS20 in specific GPCR signaling contexts in vivo using knockout or knockdown models

Hypothesis: RGS20 is required for proper termination of mu-opioid and/or melatonin receptor signaling

Experiment: Examine the functional consequences of RGS20-HOXA1 interaction using biochemical and cell-based assays

Hypothesis: The HOXA1 interaction may modulate RGS20 localization or activity

Deep Research

Falcon

(RGS20-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 16 citations 2026-02-08T20:32:34.524114

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: Human RGS20 (UniProt O76081)

Verification of Target Identity and Scope
- Identity/synonyms: Regulator of G-protein signaling 20 (RGS20), also known as RGSZ1/ZGAP1, is a member of the RZ (RGSZ) subfamily originally identified for selective activity toward Gαz; these names and properties are consistent with the UniProt description provided (O76081) (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Organism: Evidence and functional studies summarized here pertain to Homo sapiens, aligning with the requested organism (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Domains/family: RGS20 contains the canonical ~120 aa RGS (RGS-box) domain and an N‑terminal cysteine-rich region typical of the RZ subfamily, consistent with the domain annotations listed (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

1) Key Concepts and Definitions with Current Understanding
- Core biochemical function: RGS20 is a GTPase-activating protein (GAP) for heterotrimeric Gα subunits, accelerating GTP hydrolysis to terminate GPCR signaling. It exhibits strong biochemical specificity for Gαz and binds/acts on Gαi1 and Gαi3, with little to no activity toward Gαi2 or Gαs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Subfamily classification: RGS20 belongs to the RZ (RGSZ) subfamily together with RGS17 and RGS19, specialized for modulation of Gi/z-coupled GPCR pathways (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Structural features and PTMs: RGS20 has a C‑terminal RGS-box mediating GAP activity and an N‑terminal cysteine-rich segment implicated in palmitoylation and membrane association; protein–protein interactions with PKCI‑1 suggest phosphorylation-linked regulation of GAP function (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- Subcellular localization: RGS20 is detected in cytosolic and nuclear pools and can associate with membranes via its N‑terminus; stimulus-dependent relocalization (e.g., to Golgi in NGF-treated cells) has been observed (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- GPCR pathway roles: Functional studies and syntheses indicate RGS20 modulates μ‑opioid receptor signaling and directly binds the MT1 melatonin receptor (interaction mapped to MT1’s third intracellular loop), illustrating selective receptor engagement within Gi/z-regulated pathways (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

2) Recent Developments and Latest Research (emphasis 2023–2024)
- Cancer signaling mechanism (2024): In non-small cell lung cancer (NSCLC), RGS20 is upregulated and promotes proliferation by activating autophagy through inhibition of PKA–Hippo signaling, decreasing YAP phosphorylation and promoting YAP nuclear translocation. Hippo inhibitor GA‑017 rescues proliferation in RGS20 knockdown cells, while the GPCR/adenylyl cyclase activator forskolin increases YAP phosphorylation and reverses RGS20-driven phenotypes; xenograft models confirm enhanced tumorigenicity upon RGS20 overexpression (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- Pan-cancer/solid tumors (2023 review): A comprehensive review of RGS family roles in solid tumors highlights RGS20 as frequently upregulated (breast, bladder, hepatocellular carcinoma, melanoma, oral cancer) and linked to proliferation, invasion, metastasis, and poor prognosis, supporting biomarker potential and oncogenic functions (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7) (yang2023functionandregulation pages 6-8).

3) Current Applications and Real-world Implementations
- Biomarker potential in oncology: Analyses in HCC and pan-cancer cohorts found RGS20 markedly upregulated in tumors vs. adjacent normal, associated with clinical parameters (e.g., alpha-fetoprotein, tumor grade) and survival in multiple cancers, suggesting prognostic utility. These findings use TCGA and GEO data with established statistical pipelines (Biology, Aug 2022; https://doi.org/10.3390/biology11081174) (wang2022regulatorofg pages 2-4).
- Therapeutic targeting rationale: The NSCLC study provides mechanistic support for targeting RGS20 or its downstream cAMP/PKA–Hippo/YAP axis to constrain tumor growth and autophagy-mediated survival, indicating a translational avenue for drug discovery or combination strategies that modulate GPCR–G protein signaling nodes (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).

4) Expert Opinions and Analysis from Authoritative Sources
- Mechanistic synthesis in oncology: Review-level synthesis argues that dysregulated RGS proteins, including RGS20, are integral to cancer cell signaling plasticity and may serve as context-dependent biomarkers and targets; for RGS20, convergent evidence across tumor types supports a pro-tumor role when overexpressed (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7) (yang2023functionandregulation pages 6-8).
- Foundational biochemical context: Detailed biochemical and structural mapping from thesis work collating primary experiments underscores RGS20’s selective GAP activity toward Gαz and interactions that regulate its localization and GAP efficacy (e.g., PKCI‑1), supporting targeted hypotheses in diseases driven by Gi/z-coupled GPCRs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).

5) Relevant Statistics and Data from Recent Studies
- NSCLC (2024): Tissue microarrays (126 paired adenocarcinoma and 75 paired squamous samples) showed higher RGS20 expression correlating with poorer 5‑year survival; functional assays and xenografts validated proliferative and autophagy phenotypes via PKA–Hippo/YAP modulation. Although exact hazard ratios are not reported in the excerpt, the study provides experimental confirmation of mechanism and in vivo tumor growth enhancement (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- HCC and pan-cancer (2022): Differential expression in TCGA LIHC (374 tumor vs 50 normal) and GEO GSE76427 (115 tumor vs 52 normal) showed marked RGS20 upregulation; survival associations (Cox regression, Kaplan–Meier) and pathway correlations (GSEA) support prognostic relevance and links to oncogenic lincRNAs, with stated significance thresholds (e.g., p < 0.05; FDR < 0.25 for GSEA). Specific hazard ratios are provided in the original article but are not present in the excerpt (Biology, Aug 2022; https://doi.org/10.3390/biology11081174) (wang2022regulatorofg pages 2-4).

Functional Role, Pathways, and Localization (Focused Narrative)
- Primary role and substrate specificity: RGS20 accelerates GTP hydrolysis on Gαz, attenuating signaling from Gi/z-coupled GPCRs; it can act on Gαi1/i3 but not Gαi2 or Gαs. This specificity underlies its modulatory effects in neuronal and other contexts where Gαz pathways are prominent (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 16-20).
- Pathway integrations: In NSCLC, RGS20 intersects with cAMP/PKA–Hippo/YAP, consistent with a model in which altered Gi/z signaling impacts PKA activity and YAP phosphorylation/nuclear shuttling to control autophagy and proliferation (Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (ding2024rgs20promotesnonsmall pages 1-2).
- Receptor-level selectivity and GPCRs: RGS20’s direct binding to the MT1 melatonin receptor (but not MT2) exemplifies GPCR selectivity beyond its Gα preferences; prior functional work links it to μ‑opioid receptor signaling, aligning with its Gαz specialization (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).
- Subcellular site of action: Membrane association via N‑terminal cysteines and palmitoylation positions RGS20 to engage active Gα subunits at the plasma membrane; however, cytosolic/nuclear pools and stimulus-dependent trafficking indicate broader cellular dynamics that may modulate access to signaling complexes (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32).

Interaction Partners and Regulation
- Protein interactions: Reported interactors include PKCI‑1 (enhancing GAP activity; phosphorylation-linked), SCG10 (counteracting microtubule disassembly), and HOXA1 (transcription factor), pointing to cross-talk between GPCR signaling, cytoskeletal control, and transcriptional programs (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 28-32, leung2017theroleof pages 24-28).
- Post-translational regulation: Palmitoylation at the N‑terminus and phosphorylation within the cysteine-rich region likely control membrane targeting and activity; PKC-dependent modifications of Gαz can also influence the efficacy of RGS20 GAP activity, modulating pathway termination (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 24-28, leung2017theroleof pages 28-32).

Expression and Disease Associations
- Tissue expression: Foundational studies indicate brain-enriched expression, consistent with roles in neuronal GPCR pathways; disease contexts reveal RGS20 overexpression across multiple tumors (e.g., HCC, NSCLC, breast, melanoma, bladder), often associated with poor prognosis or aggressive phenotypes (Cell Communication and Signaling, Nov 2023; https://doi.org/10.1186/s12964-023-01334-7; Biology, Aug 2022; https://doi.org/10.3390/biology11081174; Cancer Cell International, Mar 2024; https://doi.org/10.1186/s12935-024-03282-9) (yang2023functionandregulation pages 6-8, wang2022regulatorofg pages 2-4, ding2024rgs20promotesnonsmall pages 1-2).

Limitations and Notes
- Antibody specificity caveat: Some earlier IHC studies used antibodies against conserved RGS-box sequences, risking cross-reactivity among RGS family members; studies drawing prognostic conclusions should be evaluated with this in mind (https://doi.org/10.14711/thesis-991012564767403412, 2017) (leung2017theroleof pages 24-28).
- Data needs: While multiple studies show upregulation and prognostic associations, precise hazard ratios and effect sizes should be extracted from full texts/tables for clinical deployment; mechanistic generalization beyond NSCLC will require additional primary studies in other tumor types (ding2024rgs20promotesnonsmall pages 1-2, wang2022regulatorofg pages 2-4).

Embedded summary table of key facts and sources
| Aspect | Key Finding | Best Evidence | Source URL | Publication date (Month YYYY) |
|---|---|---:|---|---:|
| Identity / Synonyms | Human RGS20 (Regulator of G-protein signaling 20), also reported as RGSZ1 / ZGAP1; identified as the Gz-selective GAP family member. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Protein family / Subfamily | Member of the RZ (RGSZ) subfamily (includes RGS17, RGS19, RGS20), a small RGS group specialized in Gαz regulation. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Domains & PTMs | Contains a ~120 aa C-terminal RGS (RGS-box) domain and a cysteine-rich N-terminal region; N-terminal palmitoylation and PKC-linked phosphorylation reported, mediating membrane association. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Biochemical function & Gα specificity | Acts as a GTPase-activating protein (GAP) that accelerates GTP hydrolysis on Gα subunits; shows strong activity/binding for Gαz and measurable activity with Gαi1/Gαi3, but not Gαi2 or Gαs — thus terminates Gi/z-mediated GPCR signaling. | (leung2017theroleof pages 16-20) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| GPCR pathway roles (opioid, cannabinoid, serotonin, melatonin) | Modulates μ-opioid receptor signaling (alters opioid responses) and directly binds MT1 melatonin receptor (3rd intracellular loop); review-level data implicate roles across GPCRs relevant to serotonin/cannabinoid pathways. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Subcellular localization | Reported cytosolic and nuclear pools as well as membrane-associated localization via N-terminal cysteines; stimulus-dependent relocalization (e.g., Golgi translocation in NGF-treated cells) has been observed. | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Interaction partners | Validated interactions include PKCI-1 (regulatory complex), SCG10 (neuronal cytoskeleton regulator), and HOXA1 (transcription factor); databases list many additional candidates (≈95 BioGRID entries). | (leung2017theroleof pages 28-32) | https://doi.org/10.14711/thesis-991012564767403412 | 2017 |
| Tissue expression | Baseline studies report brain-enriched expression, but recent analyses and reviews report RGS20 upregulation across multiple solid tumors (e.g., HCC, lung, breast, melanoma, bladder), indicating context-dependent expression changes in disease. | (yang2023functionandregulation pages 6-8) | https://doi.org/10.1186/s12964-023-01334-7 | Nov 2023 |
| Disease associations & mechanisms | Recent primary work (NSCLC, 2024) shows RGS20 is upregulated and promotes proliferation via autophagy by inhibiting PKA–Hippo signaling and promoting YAP nuclear translocation; other studies report RGS20 upregulation in HCC and associations with oncogenic lincRNAs and worse prognosis. | (ding2024rgs20promotesnonsmall pages 1-2) | https://doi.org/10.1186/s12935-024-03282-9 | Mar 2024 |

Table: Table summarizing core properties, biochemical specificity, localization, interactions, expression and recent disease links for human RGS20 with primary evidence and source URLs.

References (with URLs and publication dates)
- Ding X et al. RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway. Cancer Cell International. Mar 2024. URL: https://doi.org/10.1186/s12935-024-03282-9 (ding2024rgs20promotesnonsmall pages 1-2).
- Yang C et al. Function and regulation of RGS family members in solid tumours: a comprehensive review. Cell Communication and Signaling. Nov 2023. URL: https://doi.org/10.1186/s12964-023-01334-7 (yang2023functionandregulation pages 6-8).
- Leung MMH. The role of RGS20 in tumorigenesis and angiogenesis. PhD Thesis. 2017. URL: https://doi.org/10.14711/thesis-991012564767403412 (leung2017theroleof pages 24-28, leung2017theroleof pages 20-24, leung2017theroleof pages 16-20, leung2017theroleof pages 28-32).
- Wang Y et al. Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs) Harboring Oncogenic Potential and Is Markedly Upregulated in Hepatocellular Carcinoma. Biology. Aug 2022. URL: https://doi.org/10.3390/biology11081174 (wang2022regulatorofg pages 2-4).

References

  1. (leung2017theroleof pages 16-20): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

  2. (leung2017theroleof pages 28-32): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

  3. (ding2024rgs20promotesnonsmall pages 1-2): Xiaoyan Ding, Xiaoxia Li, Yanxia Jiang, Yujun Li, Hong Li, Lipeng Shang, Guilin Feng, Huhu Zhang, Ziyuan Xu, Lina Yang, Bing Li, and Robert Chunhua Zhao. Rgs20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the pka-hippo signaling pathway. Cancer Cell International, Mar 2024. URL: https://doi.org/10.1186/s12935-024-03282-9, doi:10.1186/s12935-024-03282-9. This article has 12 citations and is from a peer-reviewed journal.

  4. (yang2023functionandregulation pages 6-8): Chenglong Yang, Xiaoyuan Zhang, Xiaowen Yang, Fuming Lian, Zongrun Sun, Yong-Kang Huang, and Wenzhi Shen. Function and regulation of rgs family members in solid tumours: a comprehensive review. Cell Communication and Signaling : CCS, Nov 2023. URL: https://doi.org/10.1186/s12964-023-01334-7, doi:10.1186/s12964-023-01334-7. This article has 6 citations.

  5. (wang2022regulatorofg pages 2-4): Yulu Wang, Maria F. Setiawan, Hongde Liu, Tikam Chand Dakal, Hongjia Liu, Fangfang Ge, Oliver Rudan, Peng Chen, Chunxia Zhao, Maria A. Gonzalez-Carmona, Miroslaw T. Kornek, Christian P. Strassburg, Matthias Schmid, Jarek Maciaczyk, Amit Sharma, and Ingo G. H. Schmidt-Wolf. Regulator of g protein signaling 20 correlates with long intergenic non-coding rna (lincrnas) harboring oncogenic potential and is markedly upregulated in hepatocellular carcinoma. Biology, 11:1174, Aug 2022. URL: https://doi.org/10.3390/biology11081174, doi:10.3390/biology11081174. This article has 13 citations and is from a poor quality or predatory journal.

  6. (leung2017theroleof pages 24-28): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

  7. (leung2017theroleof pages 20-24): Manton Man Hon Leung. The role of RGS20 in tumorigenesis and angiogenesis. PhD thesis, The Hong Kong University of Science and Technology Library, 2017. URL: https://doi.org/10.14711/thesis-991012564767403412, doi:10.14711/thesis-991012564767403412. This article has 0 citations.

Citations

  1. leung2017theroleof pages 28-32
  2. leung2017theroleof pages 16-20
  3. yang2023functionandregulation pages 6-8
  4. wang2022regulatorofg pages 2-4
  5. leung2017theroleof pages 24-28
  6. leung2017theroleof pages 20-24
  7. https://doi.org/10.14711/thesis-991012564767403412,
  8. https://doi.org/10.1186/s12935-024-03282-9
  9. https://doi.org/10.1186/s12964-023-01334-7
  10. https://doi.org/10.3390/biology11081174
  11. https://doi.org/10.1186/s12964-023-01334-7;
  12. https://doi.org/10.3390/biology11081174;
  13. https://doi.org/10.14711/thesis-991012564767403412
  14. https://doi.org/10.1186/s12935-024-03282-9,
  15. https://doi.org/10.1186/s12964-023-01334-7,
  16. https://doi.org/10.3390/biology11081174,

📄 View Raw YAML

id: O76081
gene_symbol: RGS20
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  RGS20 (Regulator of G-protein signaling 20, also known as RGSZ1 or Gz-GAP) is a member
  of the RZ subfamily of RGS proteins. It functions as a GTPase-activating protein (GAP)
  that accelerates the intrinsic GTPase activity of heterotrimeric G protein alpha subunits,
  thereby terminating GPCR signaling. RGS20 exhibits strong selectivity for Galpha-z and
  can also act on Galpha-i1/i3 subunits but not Galpha-i2 or Galpha-s. The protein is
  brain-enriched with high expression in the caudate nucleus and temporal lobe. It modulates
  mu-opioid receptor and melatonin MT1 receptor signaling. RGS20 contains a C-terminal RGS
  domain for GAP activity and an N-terminal cysteine-rich region for membrane association
  via palmitoylation. The protein shuttles between cytoplasm, membrane, and nucleus and shows
  stimulus-dependent relocalization to the Golgi complex.
alternative_products:
- name: '6'
  id: O76081-1
- name: '1'
  id: O76081-2
  sequence_note: VSP_005696
- name: '2'
  id: O76081-3
  sequence_note: VSP_005697, VSP_005699
- name: '3'
  id: O76081-4
  sequence_note: VSP_005698, VSP_005700
- name: '4'
  id: O76081-5
  sequence_note: VSP_005695, VSP_005696
- name: '5'
  id: O76081-6
  sequence_note: VSP_005694, VSP_005696
existing_annotations:
- term:
    id: GO:0005096
    label: GTPase activator activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      RGS20 is a well-characterized GTPase-activating protein (GAP) that accelerates
      GTP hydrolysis on heterotrimeric G protein alpha subunits. This is the core
      biochemical function of RGS proteins, supported by direct biochemical assays
      demonstrating GAP activity with marked preference for Galpha-z over other Gi
      family members [PMID:9748279].
    action: ACCEPT
    reason: >-
      This annotation represents the core molecular function of RGS20. The protein
      was originally identified and characterized as a Gz-selective GAP. IBA annotations
      based on phylogenetic inference are appropriate for conserved RGS domain function.
    supported_by:
      - reference_id: PMID:9748279
        supporting_text: "Biochemical characterization of recombinant RGSZ1 protein revealed that RGSZ1 was indeed a GAP and, most significantly, showed a marked preference for Gzalpha over other members of the Gialpha family."

- term:
    id: GO:0009898
    label: cytoplasmic side of plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      RGS20 is anchored to membranes through palmitoylation at its N-terminal cysteine-rich
      region, allowing it to localize to the cytoplasmic face of the plasma membrane where
      it can interact with activated G protein alpha subunits [PMID:10791963, leung2017theroleof].
    action: ACCEPT
    reason: >-
      This annotation correctly describes the membrane localization mode of RGS20, which
      is consistent with its function in regulating membrane-associated GPCR signaling.
    supported_by:
      - reference_id: PMID:10791963
        supporting_text: "RGSZ, which shares with RGS-GAIP a cysteine-rich string in its N-terminal region, localized to the Golgi complex in COS-7 cells."

- term:
    id: GO:0045744
    label: negative regulation of G protein-coupled receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      By accelerating GTP hydrolysis on Galpha subunits, RGS20 terminates GPCR signaling,
      acting as a negative regulator. Studies have shown it modulates mu-opioid receptor
      and melatonin MT1 receptor signaling [PMID:20859254, leung2017theroleof].
    action: ACCEPT
    reason: >-
      This represents a core biological function of RGS20. The negative regulatory role
      in GPCR signaling is the direct consequence of its GAP activity and is well
      supported by evidence from receptor-specific studies.
    supported_by:
      - reference_id: PMID:20859254
        supporting_text: "Here, we characterized the molecular complex of the melatonin MT₁ receptor, which directly and constitutively couples to G(i) proteins and the regulator of G-protein signalling (RGS) 20"

- term:
    id: GO:0003924
    label: GTPase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      This IEA annotation is technically incorrect for RGS20. RGS proteins do not possess
      intrinsic GTPase activity; rather, they act as GTPase-activating proteins (GAPs)
      that enhance the intrinsic GTPase activity of Galpha subunits. RGS20 stimulates
      hydrolysis of GTP bound to Galpha-z/i but does not hydrolyze GTP itself.
    action: REMOVE
    reason: >-
      RGS20 does not have GTPase activity. It has GTPase activator activity (GAP activity),
      meaning it accelerates the GTPase activity of its substrates (Galpha-z, Galpha-i).
      This is a common over-annotation error where GAP function is confused with GTPase
      activity. The correct term is GO:0005096 (GTPase activator activity).
    additional_reference_ids:
      - PMID:9748279

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      RGS20 has been shown to localize to the nucleus in addition to cytoplasm and
      membrane compartments. The protein shuttles between cytoplasm/membrane and nucleus
      [PMID:10791963, UniProt O76081].
    action: ACCEPT
    reason: >-
      Nuclear localization of RGS20 is documented in the literature and UniProt. This IEA
      annotation is consistent with experimental observations showing RGS proteins can
      localize to the nucleus.
    supported_by:
      - reference_id: PMID:10791963
        supporting_text: "These results demonstrate that RGS proteins localize in the nucleus, the cytoplasm, or shuttle between the nucleus and cytoplasm as nucleo-cytoplasmic shuttle proteins."

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      Cytoplasmic localization of RGS20 is well established and has been confirmed
      by experimental studies using confocal microscopy of GFP-tagged constructs
      [PMID:10791963].
    action: ACCEPT
    reason: >-
      This annotation is consistent with experimental evidence showing cytoplasmic
      pools of RGS20.
    supported_by:
      - reference_id: PMID:10791963
        supporting_text: "RGS proteins localize differentially within cells as a result of structural differences among these proteins that do not appear to be important determinants for their G protein-regulating activities"

- term:
    id: GO:0007186
    label: G protein-coupled receptor signaling pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      RGS20 is directly involved in GPCR signaling by modulating the duration and
      intensity of signaling through its GAP activity on Galpha subunits.
    action: ACCEPT
    reason: >-
      This annotation is too general but not incorrect. RGS20 is a regulator of GPCR
      signaling pathways. The more specific term GO:0045744 (negative regulation of
      GPCR signaling) is already annotated and more informative.

- term:
    id: GO:0009968
    label: negative regulation of signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      This is a broad parent term that encompasses the more specific function of RGS20
      in negatively regulating GPCR signaling.
    action: ACCEPT
    reason: >-
      While this annotation is correct, it is more general than the specific annotation
      for GPCR signaling pathway regulation. It is acceptable as a broader classification
      but the more specific term GO:0045744 is more informative.

- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: >-
      RGS20 associates with membranes via its N-terminal cysteine-rich region through
      palmitoylation. This is documented in UniProt and supported by experimental evidence.
    action: ACCEPT
    reason: >-
      Membrane association of RGS20 is well-documented. While the more specific term
      GO:0009898 (cytoplasmic side of plasma membrane) is also annotated, this broader
      term is acceptable.

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17353931
  review:
    summary: >-
      This annotation derives from a large-scale IP-MS study of protein-protein interactions.
      RGS20 was identified in interaction screens, but this generic term does not provide
      functional insight. RGS20 binds specifically to Galpha-z/i subunits and GPCRs
      like the MT1 melatonin receptor [PMID:20859254].
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      'Protein binding' is uninformative and should be replaced with more specific
      molecular function terms. RGS20's functional interactions are better captured by
      terms like 'G-protein alpha-subunit binding' or 'GTPase activator activity'.
    supported_by:
      - reference_id: PMID:17353931
        supporting_text: "We report the first large-scale study of protein-protein interactions in human cells using a mass spectrometry-based approach."

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20859254
  review:
    summary: >-
      This study characterized the MT1 receptor/RGS20/Gi protein complex, demonstrating
      direct physical interaction between RGS20 and the melatonin MT1 receptor. A more
      specific term would be appropriate.
    action: MODIFY
    reason: >-
      The study demonstrates specific receptor binding. A more appropriate annotation
      would be a term describing interaction with GPCRs or melatonin receptors.
      However, since specific GO terms for 'melatonin receptor binding' may not exist,
      this could be replaced with 'signaling receptor binding' (GO:0005102) or kept
      with annotation indicating the specific binding partner.
    proposed_replacement_terms:
      - id: GO:0005102
        label: signaling receptor binding
    supported_by:
      - reference_id: PMID:20859254
        supporting_text: "Here, we characterized the molecular complex of the melatonin MT₁ receptor, which directly and constitutively couples to G(i) proteins and the regulator of G-protein signalling (RGS) 20"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:21516116
  review:
    summary: >-
      This study describes a high-throughput method (Stitch-seq) for generating
      interactome datasets using next-generation sequencing. RGS20 was identified
      in interactions but generic protein binding is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      High-throughput interactome studies provide evidence for interactions but the
      generic 'protein binding' term does not add functional information beyond what
      is captured by more specific terms.
    supported_by:
      - reference_id: PMID:21516116
        supporting_text: "We describe a massively parallel interactome-mapping pipeline, Stitch-seq, that combines PCR stitching with next-generation sequencing and used it to generate a new human interactome dataset"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23088713
  review:
    summary: >-
      This study characterized the interactome of the transcription factor HOXA1 and
      identified RGS20 as an interactor. The interaction with HOXA1 may be biologically
      relevant given HOXA1's role in development.
    action: KEEP_AS_NON_CORE
    reason: >-
      The HOXA1 interaction is documented in UniProt and may represent a real biological
      function, but 'protein binding' is uninformative. This interaction may not represent
      core RGS20 function as a GAP for G proteins.
    supported_by:
      - reference_id: PMID:23088713
        supporting_text: "RESULTS: To investigate the mode of action of mammalian Hoxa1, we characterized its interactome by a systematic yeast two-hybrid screening against ~12,200 ORF-derived polypeptides"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25416956
  review:
    summary: >-
      This Cell paper describes a proteome-scale map of the human interactome network
      with approximately 14,000 high-quality binary protein-protein interactions. RGS20
      interactions were identified as part of this systematic screen.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      While the interactions are valuable for understanding the RGS20 network, the
      generic 'protein binding' annotation provides no functional insight.
    supported_by:
      - reference_id: PMID:25416956
        supporting_text: "Here, we describe a systematic map of ?14,000 high-quality human binary protein-protein interactions"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29892012
  review:
    summary: >-
      This study developed an interactome perturbation framework to prioritize
      damaging missense mutations in developmental disorders. RGS20 was included in
      the interactome analysis.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The study provides valuable network-level information but 'protein binding'
      annotation is too general to be informative about RGS20 function.
    supported_by:
      - reference_id: PMID:29892012
        supporting_text: "Here we establish an experimentally and computationally integrated approach to investigate the functional impact of missense mutations in the context of the human interactome network and test our approach by analyzing ~2,000 de novo missense mutations found in autism subjects and their unaffected siblings"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:31515488
  review:
    summary: >-
      This study examined disruption of protein interactions by genetic variants
      across the allele frequency spectrum. RGS20 was included in the systematic
      evaluation of protein-protein interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic protein binding annotation from high-throughput studies does not add
      functional insight.
    supported_by:
      - reference_id: PMID:31515488
        supporting_text: "To address this gap, we leverage the ExAC database of 60,706 human exomes to investigate experimentally the impact of 2009 missense single nucleotide variants (SNVs) across 2185 protein-protein interactions, generating interaction profiles for 4797 SNV-interaction pairs, of which 421 SNVs segregate at > 1% allele frequency in human populations"

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      This study (BioPlex 3.0) created proteome-scale, cell-line-specific interaction
      networks through affinity-purification mass spectrometry, identifying 118,162
      interactions in 293T cells.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      While the BioPlex network is a valuable resource, 'protein binding' is too generic
      to be informative about specific RGS20 function.
    supported_by:
      - reference_id: PMID:33961781
        supporting_text: "The first, BioPlex 3.0, results from affinity purification of 10,128 human proteins-half the proteome-in 293T cells and includes 118,162 interactions among 14,586 proteins"

- term:
    id: GO:0007186
    label: G protein-coupled receptor signaling pathway
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-388396
  review:
    summary: >-
      Reactome pathway annotation for GPCR downstream signaling. RGS20 participates
      in this pathway by regulating G protein activity.
    action: ACCEPT
    reason: >-
      This Reactome-based annotation correctly places RGS20 in GPCR signaling pathways
      where it functions as a regulator of Galpha-z and Galpha-i signaling.

- term:
    id: GO:0003924
    label: GTPase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982020
  review:
    summary: >-
      This Reactome annotation incorrectly assigns GTPase activity to RGS20. RGS20
      does not hydrolyze GTP itself; it accelerates GTP hydrolysis by Galpha subunits.
    action: REMOVE
    reason: >-
      This is an incorrect annotation. RGS20 has GTPase activator (GAP) activity, not
      GTPase activity. The Galpha subunits (Galpha-z, Galpha-i) are the GTPases; RGS20
      activates their intrinsic GTPase activity. This appears to be a Reactome curation
      error conflating the GAP with its substrate.

- term:
    id: GO:0003924
    label: GTPase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982021
  review:
    summary: >-
      Same issue as above - incorrect assignment of GTPase activity to RGS20.
    action: REMOVE
    reason: >-
      RGS20 is a GTPase activator (GAP), not a GTPase. This annotation incorrectly
      attributes GTPase enzymatic activity to RGS20 rather than the Galpha subunits
      whose GTPase activity it enhances.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8981892
  review:
    summary: >-
      Reactome annotation indicating plasma membrane localization, consistent with
      RGS20's role in modulating membrane-associated GPCR signaling.
    action: ACCEPT
    reason: >-
      Plasma membrane localization is consistent with RGS20's function in regulating
      G protein signaling at the membrane and its palmitoylation-dependent membrane
      association.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982012
  review:
    summary: >-
      Duplicate plasma membrane annotation from Reactome pathway.
    action: ACCEPT
    reason: >-
      This is a duplicate annotation with the same term but different Reactome
      reference. Both are acceptable as they correctly indicate plasma membrane
      localization.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982018
  review:
    summary: >-
      Duplicate plasma membrane annotation from Reactome pathway.
    action: ACCEPT
    reason: >-
      Acceptable duplicate - correctly indicates plasma membrane localization.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982019
  review:
    summary: >-
      Duplicate plasma membrane annotation from Reactome pathway.
    action: ACCEPT
    reason: >-
      Acceptable duplicate - correctly indicates plasma membrane localization.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982020
  review:
    summary: >-
      Duplicate plasma membrane annotation from Reactome pathway.
    action: ACCEPT
    reason: >-
      Acceptable duplicate - correctly indicates plasma membrane localization.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8982021
  review:
    summary: >-
      Duplicate plasma membrane annotation from Reactome pathway.
    action: ACCEPT
    reason: >-
      Acceptable duplicate - correctly indicates plasma membrane localization.

- term:
    id: GO:0005802
    label: trans-Golgi network
  evidence_type: IMP
  original_reference_id: PMID:10791963
  review:
    summary: >-
      The study by Chatterjee and Fisher (2000) showed that RGSZ (RGS20) localized
      to the Golgi complex in COS-7 cells. This localization is dependent on the
      N-terminal cysteine-rich region shared with RGS-GAIP.
    action: ACCEPT
    reason: >-
      This is a well-documented experimental finding. The study specifically examined
      RGS protein localization using confocal microscopy of GFP fusion proteins and
      showed that RGSZ localized to the Golgi complex, distinct from other RGS proteins
      which showed cytoplasmic or nuclear localization.
    supported_by:
      - reference_id: PMID:10791963
        supporting_text: "RGSZ, which shares with RGS-GAIP a cysteine-rich string in its N-terminal region, localized to the Golgi complex in COS-7 cells."

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IMP
  original_reference_id: PMID:10791963
  review:
    summary: >-
      The same study demonstrated cytoplasmic localization of RGS proteins and showed
      that deletion of the N-terminal domain including the cysteine motif from RGSZ
      promoted nuclear localization, indicating the wild-type protein has cytoplasmic pools.
    action: ACCEPT
    reason: >-
      Experimental evidence from confocal microscopy studies supports cytoplasmic
      localization of RGS20.
    supported_by:
      - reference_id: PMID:10791963
        supporting_text: "Deletion of the N-terminal domain of RGSZ that includes the cysteine motif promoted nuclear localization of RGSZ."

- term:
    id: GO:0005096
    label: GTPase activator activity
  evidence_type: TAS
  original_reference_id: PMID:9748279
  review:
    summary: >-
      The original characterization of RGSZ1 (RGS20) by Glick et al. (1998) demonstrated
      that it acts as a GAP with marked preference for Galpha-z over other Galpha-i
      family members. This is the foundational paper establishing RGS20's biochemical
      function.
    action: ACCEPT
    reason: >-
      This is the primary experimental evidence establishing RGS20 as a GTPase-activating
      protein. The biochemical characterization showed clear GAP activity toward Galpha-z
      with selectivity over other Gi family members.
    supported_by:
      - reference_id: PMID:9748279
        supporting_text: "Biochemical characterization of recombinant RGSZ1 protein revealed that RGSZ1 was indeed a GAP and, most significantly, showed a marked preference for Gzalpha over other members of the Gialpha family."

- term:
    id: GO:0008277
    label: regulation of G protein-coupled receptor signaling pathway
  evidence_type: TAS
  original_reference_id: PMID:9748279
  review:
    summary: >-
      The study demonstrated that RGS20 regulates G protein signaling, consistent
      with its GAP activity toward Galpha-z. The phosphorylation state of Galpha-z
      affects susceptibility to RGS20 action.
    action: ACCEPT
    reason: >-
      This annotation correctly describes RGS20's role as a regulator of GPCR signaling.
      While the more specific term GO:0045744 (negative regulation) may be more precise,
      this term is also appropriate and supported by the cited reference.
    supported_by:
      - reference_id: PMID:9748279
        supporting_text: "Phosphorylation of Gzalpha by protein kinase C, an event known to occur in cells and that was previously shown to influence alpha-betagamma interactions of Gz, rendered the G protein much less susceptible to RGSZ1 action."

references:
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: PMID:10791963
  title: Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for
    N-terminal and RGS domain sequences as intracellular targeting motifs.
  findings:
    - statement: RGSZ localizes to the Golgi complex in COS-7 cells due to its N-terminal cysteine-rich region
    - statement: Deletion of N-terminal domain promotes nuclear localization
    - statement: RGS proteins localize in nucleus, cytoplasm, or shuttle between compartments
- id: PMID:17353931
  title: Large-scale mapping of human protein-protein interactions by mass spectrometry.
  findings:
    - statement: High-throughput IP-MS study identifying protein interactions
    - statement: RGS20 identified in interactome screens
- id: PMID:20859254
  title: Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i)
    protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling.
  findings:
    - statement: RGS20 directly and constitutively couples to MT1 melatonin receptor
    - statement: Forms ternary complex with MT1 receptor and Gi proteins
    - statement: Demonstrates receptor specificity for RGS proteins
- id: PMID:21516116
  title: Next-generation sequencing to generate interactome datasets.
  findings:
    - statement: Describes Stitch-seq methodology for interactome mapping
- id: PMID:23088713
  title: Protein interactions of the transcription factor Hoxa1.
  findings:
    - statement: RGS20 identified as HOXA1 interactor
    - statement: Suggests potential roles in cell signaling beyond core GAP function
- id: PMID:25416956
  title: A proteome-scale map of the human interactome network.
  findings:
    - statement: Proteome-scale binary protein-protein interaction map
    - statement: Approximately 14,000 high-quality human PPIs identified
- id: PMID:29892012
  title: An interactome perturbation framework prioritizes damaging missense mutations
    for developmental disorders.
  findings:
    - statement: Framework for analyzing missense mutation impact on interactome
- id: PMID:31515488
  title: Extensive disruption of protein interactions by genetic variants across the
    allele frequency spectrum in human populations.
  findings:
    - statement: Systematic evaluation of SNV impact on protein-protein interactions
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings:
    - statement: BioPlex 3.0 proteome-scale interaction network
    - statement: Cell-line-specific interaction profiling
- id: PMID:9748279
  title: RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive
    to the phosphorylation state of Gzalpha.
  findings:
    - statement: RGSZ1 (RGS20) is a GAP with marked preference for Galpha-z
    - statement: Expression limited to brain, particularly high in caudate nucleus
    - statement: PKC phosphorylation of Galpha-z reduces susceptibility to RGSZ1 action
- id: Reactome:R-HSA-388396
  title: GPCR downstream signalling
  findings: []
- id: Reactome:R-HSA-8981892
  title: Active G alpha (z) binds RGS proteins
  findings: []
- id: Reactome:R-HSA-8982012
  title: G alpha (i):RGS dissociates to inactive G alpha (i)-i1/i2/i3
  findings: []
- id: Reactome:R-HSA-8982018
  title: G alpha (z):RGS complex dissociates to give inactive G alpha (z)
  findings: []
- id: Reactome:R-HSA-8982019
  title: Active G alpha (i)-i1/i2/i3 binds RGS proteins
  findings: []
- id: Reactome:R-HSA-8982020
  title: G alpha (i)-i1/i2/i3 in G (i):RGS complex is inactivated
  findings: []
- id: Reactome:R-HSA-8982021
  title: G alpha (z) in G alpha (z):RGS complex is inactivated
  findings: []

core_functions:
  - molecular_function:
      id: GO:0005096
      label: GTPase activator activity
    description: >-
      RGS20 functions as a GTPase-activating protein (GAP) that accelerates the
      intrinsic GTPase activity of heterotrimeric G protein alpha subunits, particularly
      Galpha-z and Galpha-i1/i3. This is the core biochemical function of RGS20.
    directly_involved_in:
      - id: GO:0045744
        label: negative regulation of G protein-coupled receptor signaling pathway
    locations:
      - id: GO:0005886
        label: plasma membrane
      - id: GO:0005737
        label: cytoplasm

suggested_questions:
  - question: What is the physiological significance of RGS20's stimulus-dependent relocalization to the Golgi?
  - question: How does the interaction between RGS20 and transcription factors like HOXA1 relate to its core GAP function?
  - question: What is the functional significance of the multiple RGS20 splice isoforms?

suggested_experiments:
  - description: Characterize the substrate specificity of RGS20 isoforms for different Galpha subunits
    hypothesis: Different RGS20 isoforms may have distinct preferences for Galpha-z vs Galpha-i substrates
  - description: Investigate the role of RGS20 in specific GPCR signaling contexts in vivo using knockout or knockdown models
    hypothesis: RGS20 is required for proper termination of mu-opioid and/or melatonin receptor signaling
  - description: Examine the functional consequences of RGS20-HOXA1 interaction using biochemical and cell-based assays
    hypothesis: The HOXA1 interaction may modulate RGS20 localization or activity